All Stories

  1. Clinical and Economic Outcomes of Genome Sequencing Availability on Containing a Hospital Outbreak of Resistant Escherichia coli in Australia
  2. A stepped-wedge randomised-controlled trial assessing the implementation, impact and costs of a prospective feedback loop to promote appropriate care and treatment for older patients in acute hospitals at the end of life: study protocol
  3. Pressure injuries among admissions to a hospital in the tropics
  4. Coronavirus disease 2019 (COVID-19): an evidence map of medical literature
  5. Quality of life measured by EQ-5D at different treatment time points for coronary artery disease: protocol for a systematic review and meta-analysis
  6. Work disability in rheumatic diseases: Baseline results from an inception cohort
  7. Estimating the costs of genomic sequencing in cancer control
  8. Fixation Method for Hip Arthroplasty Stem Following Hip Fracture: A Population-Level Cost-Effectiveness Analysis
  9. Cost-utility analysis in chronic kidney disease patients undergoing kidney transplant; what pays? A systematic review
  10. Economic evaluation of health education programs: The case of adolescent reproductive health in Vietnam
  11. Using machine learning techniques to develop risk prediction models to predict graft failure following kidney transplantation: protocol for a retrospective cohort study
  12. Effectiveness of a structured, framework-based approach to implementation: the Researching Effective Approaches to Cleaning in Hospitals (REACH) Trial
  13. Selection bias and moral hazard in the Australian private health insurance market: Evidence from the Queensland skin cancer database
  14. Factors associated with non-beneficial treatments in end of life hospital admissions: a multicentre retrospective cohort study in Australia
  15. Meatal cleaning: discrepancies in need of explanation – Authors' reply
  16. Pharmaceutical use and costs in patients with coronary artery disease, using Australian observational data
  17. Machine learning in predicting graft failure following kidney transplantation: A systematic review of published predictive models
  18. The contribution of bullying victimisation to the burden of anxiety and depressive disorders in Australia
  19. Chlorhexidine versus saline in reducing the risk of catheter associated urinary tract infection: A cost-effectiveness analysis
  20. The use of modelling studies to inform planning of health services: case study of rapidly increasing endoscopy services in Australia
  21. Chlorhexidine for prevention of catheter-associated urinary tract infections: the totality of evidence – Authors' reply
  22. Cost-effectiveness of an Environmental Cleaning Bundle for Reducing Healthcare-associated Infections
  23. Fits, faints, falls and funny turns: cost and capacity savings in Queensland from the accelerated transient attack pathway initiative (ATAP)
  24. Validity and internal consistency of EQ-5D-3L quality of life tool among pre-dialysis patients with chronic kidney disease in Sri Lanka, a lower middle-income country
  25. Cost-effectiveness of interventions to reduce the risk of healthcare-acquired infections in middle-income countries: A systematic review
  26. How can we measure what happens to people who develop an infection during their hospital stay?
  27. Chlorhexidine for meatal cleaning in reducing catheter-associated urinary tract infections: a multicentre stepped-wedge randomised controlled trial
  28. Reimbursement for the cost of compression therapy for the management of venous leg ulcers in Australia
  29. Doctors’ perceptions of how resource limitations relate to futility in end-of-life decision making: a qualitative analysis
  30. Prevalence of traditional bullying and cyberbullying among children and adolescents in Australia: A systematic review and meta-analysis
  31. Applying an Implementation Framework to the Use of Evidence from Economic Evaluations in Making Healthcare Decisions
  32. How to train practising gynaecologists in total laparoscopic hysterectomy: protocol for the stepped-wedge IMAGINE trial
  33. Response to Comment on Johnson et al. Cost-effectiveness Analysis of Routine Screening Using Massively Parallel Sequencing for Maturity-Onset Diabetes of the Young in a Pediatric Diabetes Cohort: Reduced Health System Costs and Improved Patient Quality...
  34. An environmental cleaning bundle and health-care-associated infections in hospitals (REACH): a multicentre, randomised trial
  35. Development and pilot of a multicriteria decision analysis (MCDA) tool for health services administrators
  36. Cost-effectiveness analysis of an innovative model of care for chronic wounds patients
  37. Health and economic burden of antimicrobial-resistant infections in Australian hospitals: a population-based model
  38. Comparison of EQ-5D-5L and SPVU-5D for measuring quality of life in patients with venous leg ulcers in an Australian setting
  39. Comparison of the EQ-5D 3L and the SF-6D (SF-36) contemporaneous utility scores in patients with chronic kidney disease in Sri Lanka: a cross-sectional survey
  40. Cost-effectiveness Analysis of Routine Screening Using Massively Parallel Sequencing for Maturity-Onset Diabetes of the Young in a Pediatric Diabetes Cohort: Reduced Health System Costs and Improved Patient Quality of Life
  41. Cohort study of a specialist social worker intervention on hospital use for patients at risk of long stay
  42. Health benefits of an innovative model of care for chronic wounds patients in Queensland
  43. Estimating excess length of stay due to healthcare-associated infections: a systematic review and meta-analysis of statistical methodology
  44. Cost-effectiveness analysis of doctor-pharmacist collaborative prescribing for venous thromboembolism in high risk surgical patients
  45. Cost-effectiveness of interventions to improve hand hygiene in healthcare workers in middle-income hospital settings: a model-based analysis
  46. Make economics your friend
  47. Smaller clinical trials for decision making; a case study to show p-values are costly
  48. Chronic wounds in Australia: A systematic review of key epidemiological and clinical parameters
  49. Changes in knowledge and attitudes of hospital environmental services staff: The Researching Effective Approaches to Cleaning in Hospitals (REACH) study
  50. The Centre of Research Excellence in Reducing Healthcare Associated Infections
  51. Review of methods and study designs of evaluations related to clinical pathways
  52. Smaller clinical trials for decision making; using p-values could be costly
  53. Cost–utility analysis of low-intensity case management to increase contact with health services among ex-prisoners in Australia
  54. A systematic review and critical analysis of cost-effectiveness studies for coronary artery disease treatment
  55. Economic Evaluations of Guideline-Based Care for Chronic Wounds: a Systematic Review
  56. Cost-effectiveness analysis of guideline-based optimal care for venous leg ulcers in Australia
  57. Antibiotic prescribing in primary healthcare: Dominant factors and trade-offs in decision-making
  58. Improving hospital environmental hygiene with the use of a targeted multi-modal bundle strategy
  59. Reducing length of stay to improve Clostridium difficile-related health outcomes
  60. A case study of the Vitamin C sepsis bundle: Opportunity costs of delayed adoption
  61. Randomly auditing research labs could be an affordable way to improve research quality: A simulation study
  62. How much do superbugs cost Australian hospitals? An evidence-based open-access tool
  63. Economic Evaluation of a Catheter‐Associated Urinary Tract Infection Prevention Program in Nursing Homes
  64. Best practice perioperative strategies and surgical techniques for preventing caesarean section surgical site infections: a systematic review of reviews and meta‐analyses
  65. A systematic review and critical analysis of cost-effectiveness studies for coronary artery disease treatment
  66. Economic evaluation of interventions designed to reduce Clostridium difficile infection
  67. Cost-effectiveness of national health insurance programs in high-income countries: A systematic review
  68. Variation in hospital cleaning practice and process in Australian hospitals: A structured mapping exercise
  69. Reducing catheter-associated urinary tract infections in hospitals: study protocol for a multi-site randomised controlled study
  70. Australian consumer perspectives, attitudes and behaviours on antibiotic use and antibiotic resistance: a qualitative study with implications for public health policy and practice
  71. Incidence, duration and cost of futile treatment in end-of-life hospital admissions to three Australian public-sector tertiary hospitals: a retrospective multicentre cohort study
  72. An economic analysis of the benefits of sterilizing medical instruments in low-temperature systems instead of steam
  73. Effect of Total Laparoscopic Hysterectomy vs Total Abdominal Hysterectomy on Disease-Free Survival Among Women With Stage I Endometrial Cancer
  74. Time to publication for publicly funded clinical trials in Australia: an observational study
  75. “Cancer Put My Life on Hold”
  76. Cost-effectiveness of a text message programme for the prevention of recurrent cardiovascular events
  77. What is a hospital bed day worth? A contingent valuation study of hospital Chief Executive Officers
  78. Effectiveness of the cardiac-diabetes transcare program: protocol for a randomised controlled trial
  79. CHERISH (collaboration for hospitalised elders reducing the impact of stays in hospital): protocol for a multi-site improvement program to reduce geriatric syndromes in older inpatients
  80. Characteristics of national and statewide health care–associated infection surveillance programs: A qualitative study
  81. Economic evaluation of fecal microbiota transplantation for the treatment of recurrentClostridium difficileinfection in Australia
  82. Is it worth screening elective orthopaedic patients for carriage ofStaphylococcus aureus? A part-retrospective case–control study in a Scottish hospital
  83. The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae andStaphylococcus aureusin European hospitals, 2010 and 2011: a multicentre retrospective cohort study
  84. A cost‐effectiveness analysis of optimal care for diabetic foot ulcers in Australia
  85. A cost-effectiveness modelling study of strategies to reduce risk of infection following primary hip replacement based on a systematic review
  86. Reasons doctors provide futile treatment at the end of life: a qualitative study
  87. What does “futility” mean? An empirical study of doctors’ perceptions
  88. Novel application of a discrete choice experiment to identify preferences for a national healthcare-associated infection surveillance programme: a cross-sectional study
  89. Cost-Effectiveness of a National Initiative to Improve Hand Hygiene Compliance Using the Outcome of Healthcare Associated Staphylococcus aureus Bacteraemia
  90. Change to costs and lengths of stay in the emergency department and the Brisbane protocol: an observational study
  91. The role of time pressure and different psychological safety climate referents in the prediction of nurses’ hand hygiene compliance
  92. A randomized trial of fellowships for early career researchers finds a high reliability in funding decisions
  93. Improved wound management at lower cost: a sensible goal for Australia
  94. Researching effective approaches to cleaning in hospitals: protocol of the REACH study, a multi-site stepped-wedge randomised trial
  95. Understanding the determinants of Australian hospital nurses' hand hygiene decisions following the implementation of a national hand hygiene initiative
  96. Effect of Lifestyle-Focused Text Messaging on Risk Factor Modification in Patients With Coronary Heart Disease
  97. The need for cost-effectiveness analyses of antimicrobial stewardship programmes: A structured review
  98. Comparative efficacy of interventions to promote hand hygiene in hospital: systematic review and network meta-analysis
  99. Differences in identifying healthcare associated infections using clinical vignettes and the influence of respondent characteristics: a cross-sectional survey of Australian infection prevention staff
  100. Using simplified peer review processes to fund research: a prospective study
  101. Variation in health care-associated infection surveillance practices in Australia
  102. The Magnitude of Time-Dependent Bias in the Estimation of Excess Length of Stay Attributable to Healthcare-Associated Infections
  103. Quality of life after early enteral feeding versus standard care for proven or suspected advanced epithelial ovarian cancer: Results from a randomised trial
  104. Allied health growth: what we do not measure we cannot manage
  105. Futile Treatment in Hospital
  106. Cost and outcomes of assessing patients with chest pain in an Australian emergency department
  107. The cost-effectiveness of the MobileMums intervention to increase physical activity among mothers with young children: a Markov model informed by a randomised controlled trial
  108. Key beliefs of hospital nurses’ hand-hygiene behaviour: protecting your peers and needing effective reminders
  109. The Impact of Healthcare-Associated Methicillin-Resistant Staphylococcus Aureus Infections on Post-Discharge Healthcare Costs and Utilization
  110. Using a theory of planned behaviour framework to explore hand hygiene beliefs at the ‘5 critical moments’ among Australian hospital-based nurses
  111. Cost-effectiveness analysis of a hospital electronic medication management system
  112. Streamlined research funding using short proposals and accelerated peer review: an observational study
  113. Intravascular device administration sets: replacement after standard versus prolonged use in hospitalised patients--a study protocol for a randomised controlled trial (The RSVP Trial)
  114. Response to Grayson's Letter to the Editor: ‘Response to K. Page et al., ‘Costing the Australian National Hand Hygiene Initiative’’
  115. The impact of a streamlined funding application process on application time: two cross-sectional surveys of Australian researchers
  116. Randomized Controlled Trial of an Improved Version of MobileMums, an Intervention for Increasing Physical Activity in Women with Young Children
  117. Healthcare-associated infections in Australia: time for national surveillance
  118. Opportunity cost of unavailable surgical instruments in Australian hospitals
  119. Changes in healthcare-associated infections after the introduction of a national hand hygiene initiative
  120. Costing the Australian National Hand Hygiene Initiative
  121. Bridging the Gap: Exploring the Barriers to Using Economic Evidence in Healthcare Decision Making and Strategies for Improving Uptake
  122. Valuation of Hospital Bed-Days Released by Infection Control Programs: A Comparison of Methods
  123. The return to work experiences of middle-aged Australian workers diagnosed with colorectal cancer: a matched cohort study
  124. Depression in Working Adults: Comparing the Costs and Health Outcomes of Working When Ill
  125. Changes in Healthcare-Associated Staphylococcus aureus Bloodstream Infections after the Introduction of a National Hand Hygiene Initiative
  126. How costs change with infection prevention efforts
  127. Living Well With Diabetes: 24-Month Outcomes From a Randomized Trial of Telephone-Delivered Weight Loss and Physical Activity Intervention to Improve Glycemic Control
  128. Control strategies to prevent total hip replacement-related infections: a systematic review and mixed treatment comparison
  129. The economics of UTI surveillance
  130. The impact of funding deadlines on personal workloads, stress and family relationships: a qualitative study of Australian researchers
  131. The prolongation of length of stay because of Clostridium difficile infection
  132. Educational interventions for preventing vascular catheter bloodstream infections in critical care: evidence map, systematic review and economic evaluation
  133. Are educational interventions to prevent catheter-related bloodstream infections in intensive care unit cost-effective?
  134. Scholarly writing, peer-review and quality papers for Healthcare Infection
  135. Student and supervisor productivity change during nutrition and dietetic practice placements: A cohort study
  136. Moving forward with hospital cleaning
  137. The increased risks of death and extra lengths of hospital and ICU stay from hospital-acquired bloodstream infections: a case–control study
  138. Surgical site infection prevention following total hip arthroplasty in Australia: A cost-effectiveness analysis
  139. Humans, ‘things’ and space: costing hospital infection control interventions
  140. Post-discharge surgical site surveillance – where to from here?
  141. Moving MobileMums forward: protocol for a larger randomized controlled trial of an improved physical activity program for women with young children
  142. Economic evaluation of St. John's wort (Hypericum perforatum) for the treatment of mild to moderate depression
  143. Linking Scientific Evidence and Decision Making A Case Study of Hand Hygiene Interventions
  144. Surgical treatment approaches and reimbursement costs of surgical site infections post hip arthroplasty in Australia: a retrospective analysis
  145. Health service pathways for patients with chronic leg ulcers: identifying effective pathways for facilitation of evidence based wound care
  146. Australia's grant system wastes time
  147. Most relevant strategies for preventing surgical site infection after total hip arthroplasty: Guideline recommendations and expert opinion
  148. Long-term survival after intensive care unit discharge in Thailand: a retrospective study
  149. On the time spent preparing grant proposals: an observational study of Australian researchers
  150. The cost-effectiveness of total laparoscopic hysterectomy compared to total abdominal hysterectomy for the treatment of early stage endometrial cancer
  151. Key priorities for Australian infection control: summary of findings from the launch of the Centre for Research Excellence in Reducing Healthcare Associated Infections
  152. Cost effectiveness of nutrition support in the prevention of pressure ulcer in hospitals
  153. Productivity and Time Use during Occupational Therapy and Nutrition/Dietetics Clinical Education: A Cohort Study
  154. Evaluating the economics of the Australian National Hand Hygiene Initiative
  155. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol: Figure 1
  156. Development of an economic model to assess the cost-effectiveness of hawthorn extract as an adjunct treatment for heart failure in Australia
  157. Is 27 really a dangerous age for famous musicians? Retrospective cohort study
  158. Occupational therapy students’ contribution to occasions of service during practice placements in health settings
  159. Screening, isolation, and decolonisation strategies in the control of meticillin resistant Staphylococcus aureus in intensive care units: cost effectiveness evaluation
  160. Funding grant proposals for scientific research: retrospective analysis of scores by members of grant review panel
  161. Open versus closed IV infusion systems: a state based model to predict risk of catheter associated blood stream infections
  162. Bureaucracy savings should go to research
  163. The Importance of Good Data, Analysis, and Interpretation for Showing the Economics of Reducing Healthcare-Associated Infection
  164. The Working After Cancer Study (WACS): a population-based study of middle-aged workers diagnosed with colorectal cancer and their return to work experiences
  165. The Time-Dependent Bias and its Effect on Extra Length of Stay due to Nosocomial Infection
  166. Time-dependent analysis of extra length of stay and mortality due to ventilator-associated pneumonia in intensive-care units of ten limited-resources countries: findings of the International Nosocomial Infection Control Consortium (INICC)
  167. Potential of St John's Wort for the Treatment of Depression: The Economic Perspective
  168. Time-dependent analysis of length of stay and mortality due to urinary tract infections in ten developing countries: INICC findings
  169. Cutting random funding decisions
  170. The use of economic evaluation in CAM: an introductory framework
  171. A policy case study of blood in Australia
  172. Excess Length of Stay Due to Central Line–Associated Bloodstream Infection in Intensive Care Units in Argentina, Brazil, and Mexico
  173. Cost-Effectiveness of a Central Venous Catheter Care Bundle
  174. Malnutrition and pressure ulcer risk in adults in Australian health care facilities
  175. Living Well with Diabetes: a randomized controlled trial of a telephone-delivered intervention for maintenance of weight loss, physical activity and glycaemic control in adults with type 2 diabetes
  176. Multiple Health Behavior Changes and Co-variation in a Telephone Counseling Trial
  177. Estimating the Cost of Health Care–Associated Infections: Mind Your p’s and q’s
  178. Obesity in pregnancy: outcomes and economics
  179. The costs arising from pressure ulcers attributable to malnutrition
  180. The Cost-effectiveness of Routine Follow-up After Primary Total Hip Arthroplasty
  181. Cost-Effectiveness of an Intervention to Reduce Emergency Re-Admissions to Hospital among Older Patients
  182. Cost-Effectiveness of a Telephone-Delivered Intervention for Physical Activity and Diet
  183. Using a Longitudinal Model to Estimate the Effect of Methicillin-resistant Staphylococcus aureus Infection on Length of Stay in an Intensive Care Unit
  184. Economic rationale for infection control in Australian hospitals
  185. Modeling Length of Stay in Hospital and Other Right Skewed Data: Comparison of Phase-Type, Gamma and Log-Normal Distributions
  186. Telephone Counseling for Physical Activity and Diet in Primary Care Patients
  187. Cost effectiveness of antimicrobial catheters in the intensive care unit: addressing uncertainty in the decision
  188. Economics and Preventing Healthcare Acquired Infection
  189. Perinatal HIV transmission and the cost-effectiveness of screening at 14 weeks gestation, at the onset of labour and the rapid testing of infants
  190. The International Nosocomial Infection Control Consortium (INICC): Goals and objectives, description of surveillance methods, and operational activities
  191. Nosocomial Infection, the Deficit Reduction Act, and Incentives for Hospitals
  192. Overcrowding and understaffing in modern health-care systems: key determinants in meticillin-resistant Staphylococcus aureus transmission
  193. Who bears the cost of healthcare-acquired surgical site infection?
  194. The Logan Healthy Living Program: A cluster randomized trial of a telephone-delivered physical activity and dietary behavior intervention for primary care patients with type 2 diabetes or hypertension from a socially disadvantaged community — Rationale...
  195. Catheter-related bloodstream infections in intensive care units: a systematic review with meta-analysis
  196. A systematic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units
  197. Competing risks models and time-dependent covariates
  198. Mental health in the workplace: Using the ICF to model the prospective associations between symptoms, activities, participation and environmental factors
  199. Factors associated with health care-acquired urinary tract infection
  200. Which presenteeism measures are more sensitive to depression and anxiety?
  201. A review of the cost-effectiveness of face-to-face behavioural interventions for smoking, physical activity, diet and alcohol
  202. Effect of Healthcare-Acquired Infection on Length of Hospital Stay and Cost
  203. Economics and Preventing Hospital-Acquired Infection: Broadening the Perspective
  204. Cost-effectiveness analyses and modelling the lifetime costs and benefits of health-behaviour interventions
  205. A Cost-effectiveness Analysis of Two Rehabilitation Support Services for Women with Breast Cancer
  206. Modeling the economic losses from pressure ulcers among hospitalized patients in Australia
  207. Effect of Pressure Ulcers on Length of Hospital Stay
  208. Correcting for bias when estimating the cost of hospital-acquired infection: an analysis of lower respiratory tract infections in non-surgical patients
  209. A comparison of competing methods for the detection of surgical-site infections in patients undergoing total arthroplasty of the knee, partial and total arthroplasty of hip and femoral or similar vascular bypass
  210. Would Universal Antenatal Screening for HIV Infection Be Cost‐Effective in a Setting of Very Low Prevalence? Modelling the Data for Australia
  211. Modeling the Costs of Hospital-Acquired Infections in New Zealand
  212. The cost effectiveness of universal antenatal screening for HIV in New Zealand
  213. The Prevalence and Estimates of the Cumulative Incidence of Hospital-Acquired Infections Among Patients Admitted to Auckland District Health Board Hospitals in New Zealand
  214. Cost data for individual patients included in clinical studies: no amount of statistical analysis can compensate for inadequate costing methods
  215. The epic project: developing national evidence-based guidelines for preventing healthcare associated infections
  216. The health economic implications of treatment with quetiapine: an audit of long-term treatment for patients with chronic schizophrenia
  217. Adverse events in British hospitals
  218. An economic model to assess the cost and benefits of the routine use of silver alloycoated urinary catheters to reduce the risk of urinary tract infections in catheterized patients
  219. The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed
  220. What do We Know About Complementary Medicine? What Should We Know?